Hepatocellular Cancer Terminated Phase 2 Trials for Doxorubicin (DB00997)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02958163Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)Treatment